Amy Kempf

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann, Prerna Arora, Rüdiger Groß et al. · Cell · 2021 · 1K citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Markus Hoffmann, Nadine Krüger, Sebastian Schulz et al. · Cell · 2021 · 955 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger et al. · Cell Reports · 2021 · 242 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency

Lu Zhang, Amy Kempf, Inga Nehlmeier et al. · Cell · 2024 · 121 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +7

SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination

Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 92 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17